Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

C. Serrano, S. Bauer, D. Gómez-Peregrina, Y. K. Kang, R. L. Jones, P. Rutkowski, O. Mir, M. C. Heinrich, W. D. Tap, K. Newberry, A. Grassian, H. Shi, S. Bialick, P. Schöffski, M. A. Pantaleo, M. von Mehren, J. C. Trent, S. George